For its first fiscal quarter (ending March 31), Tenet Healthcare Corp (NYSE: THC) has reported a 1443% increase in E.P.S. from $1.40 a year ago to $21.60 in the current quarter. This performance was $19.90 better than the consensus estimate of $1.70. E.P.S. were $26.22 for the latest four quarters through March 31 versus $3.94 for the same period a year ago — an increase of 565%.
Recent Price Action
On 4/30/24, Tenet Healthcare Corp (NYSE: THC) stock enjoyed a major increase of 13.3%, closing at $112.29. Moreover, exceptionally high trading volume at 312% of normal accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 18.4% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, THC is expected to continue to be a major Value Builder.
Tenet Healthcare has a current Value Trend Rating of B (Positive). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Tenet Healthcare has a neutral Appreciation Score of 45 but a very high Power Rating of 98, producing the Positive Value Trend Rating.
Rating Review
In light of this encouraging new earnings information and very positive price change we are reviewing our current Overall Rating of B. We would continue to view the shares with optimism pending completion of this review in the next several days.
Be the first to comment